4221 - 4230 of 5832 Results
Title
Year
- Increased dopaminergic function in the thalamus is associated with excessive daytime sleepiness2017OPENTitle: Increased dopaminergic function in the thalamus is associated with excessive daytime sleepinessJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 43Issue #:Start Page: 25End Page: 30Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2017.11.1137Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/83291977/Increased_dopaminergic_function_in_YOUSAF_Firstonline12December2017_GREEN_AAM_CC_BY_NC_ND_.pdfCitation Count: 13
- Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons2017OPENTitle: Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neuronsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 111Issue #:Start Page: 26End Page: 35Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.12.005Best OA location URL: https://europepmc.org/articles/pmc5803451?pdf=renderCitation Count: 113
-
OPENTitle: Associations Between Tau, β-Amyloid, and Cognition in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 75Issue #: 2Start Page: 227End Page: 227Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2017.3713Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2664949/jamaneurology_winer_2017_oi_170089.pdfCitation Count: 59
- The Anthelmintic Drug Niclosamide and Its Analogues Activate the Parkinson's Disease Associated Protein Kinase PINK12017OPENTitle: The Anthelmintic Drug Niclosamide and Its Analogues Activate the Parkinson's Disease Associated Protein Kinase PINK1Journal Name: ChemBioChemPublisher: WileyVol: 19Issue #: 5Start Page: 425End Page: 429Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/cbic.201700500Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cbic.201700500Citation Count: 49
- Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohort2017OPENTitle: Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohortJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 47Issue #:Start Page: 3End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.12.006Best OA location URL: https://europepmc.org/articles/pmc5803409?pdf=renderCitation Count: 47
-
OPENTitle: Rab29 activation of the Parkinson's disease‐associated LRRK2 kinaseJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 37Issue #: 1Start Page: 1End Page: 18Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embj.201798099Best OA location URL: https://doi.org/10.15252/embj.201798099Citation Count: 320
- Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term2017OPENTitle: Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long termJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 135Issue #: 1Start Page: 65End Page: 83Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-017-1792-9Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs00401-017-1792-9.pdfCitation Count: 169
- Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features2017OPENTitle: Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease FeaturesJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 282End Page: 288Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27232Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27232Citation Count: 130
-
OPENTitle: Effects of Exercise on Non-motor Symptoms in Parkinson’s DiseaseJournal Name: Clinical TherapeuticsPublisher: Elsevier BVVol: 40Issue #: 1Start Page: 8End Page: 15Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.clinthera.2017.11.004Best OA location URL: http://www.clinicaltherapeutics.com/article/S0149291817310664/pdfCitation Count: 90
- The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein2017OPENTitle: The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synucleinJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 110Issue #:Start Page: 68End Page: 81Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2017.11.006Best OA location URL: http://manuscript.elsevier.com/S0969996117302723/pdf/S0969996117302723.pdfCitation Count: 44